Polpharma Group expanding its capacity for biologicals

Extensive biological development and production capabilities that Polpharma Group is establishing in Poland are intended not only to support its own biosimilars pipeline. The group is also creating a significant contract development and manufacturing organisation (CDMO), vice-president Hannes Teissl told Aidan Fry.